SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Accounting Policies [Abstract] |
|
| SCHEDULE OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH |
The
Company considers all highly liquid securities with original maturities of three months or less when acquired to be cash equivalents.
The Company’s cash composition was as follows:
SCHEDULE
OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH
| | |
March
31, 2026 | | |
December
31, 2025 | |
| | |
| | |
| |
| Cash
and cash equivalents | |
$ | 30,263,740 | | |
$ | 8,052,621 | |
| Restricted
cash | |
| 2,050,000 | | |
| 2,050,000 | |
| Total
cash, cash equivalents and restricted cash | |
$ | 32,313,740 | | |
$ | 10,102,621 | |
|
| SCHEDULE OF INVENTORY |
SCHEDULE
OF INVENTORY
| | |
March
31, 2026 | | |
December
31, 2025 | |
| Inventory,
component parts | |
| 1,383,777 | | |
| 2,413,821 | |
| Inventory,
finished goods | |
| 3,214,504 | | |
| 3,136,347 | |
| Allowance | |
| (1,300,000 | ) | |
| (1,300,000 | ) |
| Inventory-total | |
| 3,298,281 | | |
| 4,250,168 | |
|
| SCHEDULE OF ANTI-DILUTIVE COMMON STOCK EQUIVALENTS |
The
Company had the following anti-dilutive common stock equivalents on March 31, 2026, and December 31, 2025:
SCHEDULE
OF ANTI-DILUTIVE COMMON STOCK EQUIVALENTS
| | |
March
31, 2026 | | |
December
31, 2025 | |
| Stock
warrants | |
| 321,750 | | |
| 1,588,417 | |
| Stock
options | |
| 31,721,286 | | |
| 31,838,322 | |
| Unvested
restricted stock | |
| 4,022,391 | | |
| 4,988,817 | |
| Convertible
notes | |
| 15,190,014 | | |
| 14,863,205 | |
| Preferred
stock | |
| 10,249,997 | | |
| 10,999,997 | |
| Anti-dilutive
securities | |
| 61,505,438 | | |
| 64,278,758 | |
|